Jonathan Wolleben Analyst Performance

Managing Director at JMP Securities

Jonathan Wolleben is a stock analyst at JMP Securities in the medical sector, covering 20 publicly traded companies. Over the past year, Jonathan Wolleben has issued 33 stock ratings, including and buy recommendations. While full access to Jonathan Wolleben's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Jonathan Wolleben's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ranking: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 61 Last 5 Years
Buy Recommendations: 100.00% 59 Buy Ratings
Companies Covered: 20 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	100.0%	59 ratings
Hold	0.0%	0 ratings
Sell	0.0%	0 ratings

the majority (100.0%) have been Buy recommendations.

Best & Worst Calls

Best Call
0000.0%
MDGL
Feb 2022
Subscribe to MarketBeat All Access to get analyst recommendation ROI.
Worst Call
000.0%
PRQR
Sep 2021
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	95.0% of companies on NASDAQ	19 companies
NYSE	5.0% of companies on NYSE	1 company

Jonathan Wolleben, an analyst at JMP Securities, currently covers 20 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 20 companies	100.0%

Jonathan Wolleben of JMP Securities specializes in stock coverage within the Medical sector.

Coverage Industries

Industry	Percentage
MED - BIOMED/GENE 12 companies	60.0%
MED - DRUGS 7 companies	35.0%
PHARMACEUTICAL PREPARATIONS 1 company	5.0%

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
KALV KalVista Pharmaceuticals	9/12/2025	Boost Price Target	$14.81	$28.00	Market Outperform
MDGL Madrigal Pharmaceuticals	8/20/2025	Boost Price Target	$379.55	$485.00	Market Outperform
LRMR Larimar Therapeutics	8/15/2025	Lower Price Target	$4.30	$18.00	Market Outperform
PHVS Pharvaris	8/13/2025	Lower Price Target	$21.47	$52.00	Market Outperform
ATXS Astria Therapeutics	8/13/2025	Boost Price Target	$6.88	$26.00	Market Outperform
QNCX Quince Therapeutics	8/12/2025	Lower Price Target	$1.57	$8.00	Market Outperform
CRNX Crinetics Pharmaceuticals	8/11/2025	Lower Price Target	$26.85	$86.00	Market Outperform
PTGX Protagonist Therapeutics	8/7/2025	Boost Price Target	$53.42	$69.00	Market Outperform
MIRM Mirum Pharmaceuticals	8/7/2025	Set Price Target	$59.41	$81.00	Market Outperform
GPCR Structure Therapeutics	8/7/2025	Lower Price Target	$16.31	$87.00	Market Outperform
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
RYTM Rhythm Pharmaceuticals	8/6/2025	Boost Price Target	$89.85	$135.00	Market Outperform
QNCX Quince Therapeutics	8/5/2025	Initiated Coverage	$1.63	$9.00	Market Outperform
ALT Altimmune	7/10/2025	Lower Price Target	$4.21	$15.00	Market Outperform
KALV KalVista Pharmaceuticals	7/8/2025	Boost Price Target	$15.69	$27.00	Market Outperform
PRQR ProQR Therapeutics	6/27/2025	Reiterated Rating	$2.16	$8.00	Market Outperform
RYTM Rhythm Pharmaceuticals	6/26/2025	Reiterated Rating	$62.19	$84.00	Market Outperform
DBVT DBV Technologies	6/26/2025	Reiterated Rating	$9.06	$21.00	Market Outperform
SKYE Skye Bioscience	6/24/2025	Reiterated Rating	$3.16	$15.00	Market Outperform
GPCR Structure Therapeutics	6/23/2025	Reiterated Rating	$21.73	$89.00	Market Outperform
DBVT DBV Technologies	5/27/2025	Boost Price Target	$8.41	$21.00	Market Outperform
AURA Aura Biosciences	5/23/2025	Reiterated Rating	$5.91	$19.00	Market Outperform
CLSD Clearside Biomedical	5/16/2025	Reiterated Rating	$13.23	$75.00	Market Outperform
MIRM Mirum Pharmaceuticals	5/9/2025	Boost Price Target	$45.07	$76.00	Market Outperform
MDGL Madrigal Pharmaceuticals	4/24/2025	Reiterated Rating	$308.00	$443.00	Market Outperform
MBX MBX Biosciences	4/10/2025	Initiated Coverage	$6.12	$38.00	Market Outperform
AURA Aura Biosciences	3/26/2025	Set Price Target	$5.25	$19.00
PTGX Protagonist Therapeutics	2/7/2025	Reiterated Rating	$39.61	$58.00	Market Outperform
ATXS Astria Therapeutics	1/31/2025	Initiated Coverage	$7.49	$26.00	Outperform
KALV KalVista Pharmaceuticals	1/31/2025	Initiated Coverage	$8.77	$19.00	Outperform
PHVS Pharvaris	1/31/2025	Boost Price Target	$18.06	$55.00	Market Outperform
BCRX BioCryst Pharmaceuticals	1/31/2025	Reiterated Rating	$7.96	$18.00	Market Outperform
DBVT DBV Technologies	1/10/2025	Reiterated Rating	$4.14	$10.00	Market Outperform
MDGL Madrigal Pharmaceuticals	1/10/2025	Reiterated Rating	$330.62	$427.00	Market Outperform

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.